Top Korean Botox Brands To Try In 2026

Trying to sort out Korean Botox brands in 2026 can get confusing fast. One clinic mentions Nabota, another says Letybo, and then you see Innotox, Rentox, Liztox, and Coretox in the mix.

If you are in the United States, there is one shortcut that matters right away: the Korean-developed options with FDA-cleared cosmetic labels are Jeuveau and Letybo. The other names are real products in other markets, but they are not the standard FDA-approved cosmetic choices for U.S. practice.

This guide walks you through the differences that actually matter for wrinkles, fine lines, and safer decision-making.

Key Takeaways

• Nabota is the Korean toxin behind Jeuveau, and Hugel's U.S. cosmetic brand is Letybo. Those are the Korean-developed names with clear U.S. cosmetic approval pathways.
• Innotox stands out because it is a ready-to-use liquid botulinum toxin, which means no reconstitution step before injection.
• Coretox gets attention for its complexing protein-free design, while Liztox and Rentox matter more in international markets than in everyday U.S. clinic shelves.
• For U.S. patients, the safest move is to ask to see the labeled vial, confirm the exact brand name, and make sure your injector is using an FDA-approved product sourced through a licensed channel.

Key Features of Korean Botox Brands

Korean botulinum toxins are built around botulinum toxin type A, a purified neurotoxin derived from clostridium botulinum. In cosmetic medicine, the goal is simple: relax targeted facial muscles so dynamic wrinkles soften while your face still looks like you.

What makes these brands worth comparing is not hype. It is the mix of regulatory status, formulation style, storage requirements, and how easy each product is to use correctly in a real clinic.

As of April 2026, CDC lists only Botox, Daxxify, Dysport, Jeuveau, Letybo, and Xeomin as FDA-approved cosmetic botulinum toxin products in the U.S. That single fact instantly changes how an American patient should read any list of Korean brands.

https://www.youtube.com/watch?v=uoirgLsS7k0

High quality and safety standards

The strongest Korean names in the U.S. conversation are the ones backed by official review. In the FDA's 2024 approval summary, Letybo was cleared on February 29, 2024 for moderate to severe glabellar lines after three trials involving 1,271 patients.

Jeuveau, which is made from Daewoong Pharmaceuticals' Nabota, has been FDA-approved in the U.S. since 2019 for the same frown-line area. That matters because it gives U.S. patients a regulated path to try Korean-developed toxin technology without relying on gray-market imports.

• Check the exact label name. In U.S. practice, ask whether the vial says Jeuveau or Letybo, not just "Korean Botox."
• Ask to see the sealed vial before treatment. This is the easiest way to confirm authenticity and lot details.
• Do not compare units across brands as if they are identical. Official labels for both Jeuveau and Letybo state that their potency units are product-specific and not interchangeable with other toxin brands.

Competitive pricing

Korean-developed toxins can offer real value, but in the U.S. the safer comparison is not just price. It is price plus brand name, unit count, and sourcing.

This is where many articles stay vague. A low quote means very little if the clinic will not tell you the brand, the number of units, or whether touch-ups are extra.

For glabellar lines, both Jeuveau and Letybo use an official cosmetic dose of 20 units split across 5 injection sites. Both labels also say retreatment should be no more frequent than every 3 months. That gives you a practical way to judge whether a quote sounds realistic.

If a clinic advertises a bargain deal without listing units, treatment area, or brand, slow down. In cosmetic medicine, a cheap mystery vial is never a smart bargain.

Innovative formulations

Korean brands do stand out for formulation variety. That is the real reason professionals keep talking about them.

• Innotox is a ready-to-use liquid, so there is no saline reconstitution step before treatment.
• Coretox is known for being a complexing protein-free formulation, which appeals to clinics that think carefully about repeated long-term use.
• Jeuveau and Letybo bring the biggest practical advantage for U.S. patients because they pair Korean development with official American cosmetic labeling.

That said, no formulation can rescue poor technique. The injector still matters more than the marketing line on the box.

Botulax (Letybo)

Botulax is Hugel's well-known Korean toxin brand, while Letybo is the FDA-approved U.S. brand name tied to the same Korean manufacturer. For American patients, that naming difference matters a lot.

If a provider says "Botulax" in the United States, the smart follow-up question is whether they actually mean Letybo, the approved product, or an imported vial that falls outside the standard U.S. approval path.

https://www.youtube.com/watch?v=n2E7U_rvl1s

Features & Description (Botulax)

Hugel manufactures both Botulax and Letybo. On Hugel's brand page, Botulax is positioned as a high-purity, stable-potency toxin, while Letybo is the brand actively expanding across the USA and other regulated markets.

In the FDA's 2024 approval package, Letybo was cleared for the temporary improvement of moderate to severe glabellar lines in adults. The labeled treatment is 20 units across 5 sites, and unopened vials should be refrigerated at 2 to 8 degrees Celsius.

• Best fit:S. patients who want a Korean-developed option with FDA-cleared cosmetic labeling.
• Practical upside: Clear American labeling, standardized dosing, and a familiar glabellar-line protocol.
• Watch-out: Do not assume every vial called Botulax is the same as what a licensed U.S. practice uses under the Letybo name.

Pros & Cons (Botulax)

Nabota (Jeuveau)

Nabota is one of the strongest Korean names in this category because it already has a mature U.S. identity. In American clinics, you will usually hear it called Jeuveau.

That makes Nabota easier to evaluate than many other imported names. You are not guessing about approval status, dose, or what the product is supposed to treat.

https://www.youtube.com/watch?v=R5RijfpseWc

Features & Description (Nabota)

Daewoong Pharmaceuticals developed Nabota, and Evolus markets it in the U.S. as Jeuveau. The official Jeuveau label uses the same cosmetic target area as Letybo, moderate to severe glabellar lines, with 20 units injected at 5 sites.

A Phase 3 head-to-head trial in 540 adults found prabotulinumtoxinA, the active ingredient in Jeuveau, was noninferior to onabotulinumtoxinA for glabellar lines. That is useful if you are comparing it with long-established Western botulinum toxin products.

• Early-result detail: Evolus says about 50% of patients begin showing improvement after 2 days, with roughly 69% reaching complete results by day 30.
• Safety detail: In the U.S. prescribing information, the most common adverse reaction was headache at 12%, followed by eyelid ptosis at 2%.
• Best fit: Patients who want a Korean-developed option with the clearest U.S. cosmetic track record.

Pros & Cons (Nabota)

Innotox

Innotox gets attention for one reason above all others: it arrives as a liquid. That sounds like a small detail, but in clinic workflow it changes how the product is handled.

For patients, the bigger point is simpler. Ready-to-use can be convenient, but it does not cancel out the need for careful storage, genuine sourcing, and a trained injector.

Features & Description (Innotox)

Medytox describes Innotox as a liquid injectable botulinum toxin product for adults with moderate to severe glabellar wrinkles. On the company's product page, it is stored at 2 to 8 degrees Celsius and sold in 25-unit, 50-unit, and 100-unit presentations.

The ready-to-use format can reduce one handling step because there is no reconstitution before treatment. In a busy practice, that can help dosing consistency, but only if the vial has been stored and transported correctly from the start.

• Best fit: Clinics that value a liquid format and already know how to manage cold-chain handling tightly.
• Main limitation for U.S. readers: Innotox is not among the FDA-approved cosmetic botulinum toxin products listed for the U.S. market.
• Smart question to ask: Was this vial sourced through a licensed U.S. channel, or is it an imported product outside normal FDA-approved practice?

Pros & Cons (Innotox)

How to Choose the Best Korean Botox Brand

For most U.S. patients, choosing the best brand comes down to three things: approved status, formulation style, and how transparent your injector is. Brand curiosity is fine, but safety needs to lead the conversation.

Longevity of results

CDC says cosmetic botulinum toxin effects usually last several months. In day-to-day practice, many patients still plan maintenance around the 3 to 4 month range, but your muscle strength, dose, and treatment area can shift that timeline.

• If your result fades unusually fast, the first question is not always the brand. It may be dose or injection pattern.
• If a clinic recommends very frequent toxin visits, compare that advice with the official labeled minimum of every 3 months for Jeuveau and Letybo glabellar treatment.
• If long duration is your top priority, ask your injector how many units they plan to use and why.

FDA approvals and certifications

This is the section that should shape your final decision in the united states. A brand can be popular abroad and still be the wrong choice for a U.S. clinic visit.

CDC's June 24, 2024 investigation into counterfeit or mishandled botulinum toxin injections recorded 17 people in 9 states with harmful reactions, and 13 of them were hospitalized. That is why licensed sourcing matters so much.

• Best U.S. shortcut: If you want a Korean-developed toxin in America, focus first on Jeuveau and Letybo.
• Ask to see the vial: You should be able to confirm the brand name, lot, and label before injection.
• Walk away from mystery sourcing: In late 2025, FDA also sent warning letters over illegal marketing of unapproved botulinum toxin products online.

Purity and formulation type

Purity matters, but it matters in context. A high-purity formula is helpful only when the product is authentic, correctly stored, properly diluted when needed, and injected by someone who understands facial anatomy.

If you want the simplest answer, here it is: pick the product your qualified injector can source legally, explain clearly, and dose confidently. That beats chasing a trendy vial every time.

Conclusion

Korean botox brands bring real innovation, especially with names like Innotox, Nabota, Botulax, Rentox, Liztox, and Coretox. But for U.S. patients, the safest Korean-developed paths are still Jeuveau and Letybo because their approval status is clear and their labeling is easy to verify.

Use longevity, formulation style, and injector transparency to choose the right fit for your wrinkles, then make sure the vial in the room matches the brand you were promised.